A series
of mononuclear non-oxido vanadium(IV) complexes, [VIV(L1–4)2] (1–4), featuring
tridentate bi-negative ONS chelating S-alkyl/aryl-substituted
dithiocarbazate ligands H2L1–4, are reported.
All the synthesized non-oxido VIV compounds are characterized
by elemental analysis, spectroscopy (IR, UV–vis, and EPR),
ESI-MS, as well as electrochemical techniques (cyclic voltammetry).
Single-crystal X-ray diffraction studies of 1–3 reveal that the mononuclear non-oxido VIV complexes
show distorted octahedral (1 and 2) or trigonal
prismatic (3) arrangement around the non-oxido VIV center. EPR and DFT data indicate the coexistence of mer and fac isomers in solution, and ESI-MS
results suggest a partial oxidation of [VIV(L1–4)2] to [VV(L1–4)2]+ and [VVO2(L1–4)]−; therefore, all these three complexes are plausible
active species. Complexes 1–4 interact
with bovine serum albumin (BSA) with a moderate binding affinity,
and docking calculations reveal non-covalent interactions with different
regions of BSA, particularly with Tyr, Lys, Arg, and Thr residues. In vitro cytotoxic activity of all complexes is assayed
against the HT-29 (colon cancer) and HeLa (cervical cancer) cells
and compared with the NIH-3T3 (mouse embryonic fibroblast) normal
cell line by MTT assay and DAPI staining. The results suggest that
complexes 1–4 are cytotoxic in nature
and induce cell death in the cancer cell lines by apoptosis and that
a mixture of VIV, VV, and VVO2 species could be responsible for the biological activity.